Home Articles List Article Information
Iranian Journal of Pharmaceutical Research
Journal Archive
Volume Volume 18 (2019)
Volume Volume 17 (2018)
Volume Volume 16 (2017)
Volume Volume 15 (2016)
Volume Volume 14 (2015)
Volume Volume 13 (2014)
Volume Volume 12 (2013)
Volume Volume 11 (2012)
Volume Volume 10 (2011)
Volume Volume 9 (2010)
Volume Volume 8 (2009)
Volume Volume 7 (2008)
Volume Volume 6 (2007)
Volume Volume 5 (2006)
Volume Volume 4 (2005)
Volume Volume 3 (2004)
Volume Volume 2 (2003)
Volume Volume 1 (2002)
Haeri, A. (2017). Combined Approach of Ligand Targeted and Stimuli-triggered Nanocarriers: a State-of-the-art Strategy for Cancer Treatment. Iranian Journal of Pharmaceutical Research, 16(2), 411-412. doi: 10.22037/ijpr.2017.2110
Azadeh Haeri. "Combined Approach of Ligand Targeted and Stimuli-triggered Nanocarriers: a State-of-the-art Strategy for Cancer Treatment". Iranian Journal of Pharmaceutical Research, 16, 2, 2017, 411-412. doi: 10.22037/ijpr.2017.2110
Haeri, A. (2017). 'Combined Approach of Ligand Targeted and Stimuli-triggered Nanocarriers: a State-of-the-art Strategy for Cancer Treatment', Iranian Journal of Pharmaceutical Research, 16(2), pp. 411-412. doi: 10.22037/ijpr.2017.2110
Haeri, A. Combined Approach of Ligand Targeted and Stimuli-triggered Nanocarriers: a State-of-the-art Strategy for Cancer Treatment. Iranian Journal of Pharmaceutical Research, 2017; 16(2): 411-412. doi: 10.22037/ijpr.2017.2110

Combined Approach of Ligand Targeted and Stimuli-triggered Nanocarriers: a State-of-the-art Strategy for Cancer Treatment

Editorial, Volume 16, Issue 2, Spring 2017, Page 411-412  XML PDF (205.01 K)
DOI: 10.22037/ijpr.2017.2110
Author
Azadeh Haeri
Department of Pharmaceutics, School of Pharmacy, Shahid Beheshti University of Medical Sciences, Tehran, Iran
Statistics
Article View: 1,439
PDF Download: 20,717